Loneliness severity and heart disease risk in older Chinese rural adults: a machine learning-based cross-sectional study

中国农村老年人孤独感严重程度与心脏病风险:一项基于机器学习的横断面研究

阅读:1

Abstract

BACKGROUND: Loneliness is an important psychosocial determinant of cardiovascular health, yet its role in heart disease among older adults in rural China is underexplored. METHODS: Using 2020 China Health and Retirement Longitudinal Study (CHARLS) data, the analytic sample comprised 5767 rural residents aged ≥60 years. Loneliness was measured with a four-level 10-item Center for Epidemiologic Studies Depression Scale (CESD-10) item. Covariate-adjusted, residence-stratified logistic regressions assessed associations. Six machine learning classifiers (including logistic regression and gradient boosting decision tree) were trained with a stratified 70/30 split and evaluated by area under the receiver operating characteristic curve (ROC-AUC), area under the precision–recall curve (PR-AUC), accuracy, precision, recall, and F1; decision-curve analysis quantified net benefit. SHapley Additive exPlanations (SHAP) provided model interpretability. RESULTS: A graded association was observed: higher loneliness severity corresponded to higher odds of heart disease, with stronger effects in rural than urban strata. Logistic regression and gradient boosting decision tree showed the best discrimination (ROC-AUC 0.753 and 0.750; PR-AUC 0.400 and 0.388). Decision-curve analysis indicated greater net benefit for these models across clinically relevant thresholds. SHAP ranked dyslipidemia, sex, age, hypertension, and diabetes as leading contributors, and identified loneliness as an independent, quantifiable predictor. CONCLUSIONS: Loneliness is a salient correlate of self-reported heart disease in rural Chinese older adults. Incorporating brief loneliness screening into routine primary care may aid risk stratification in under-resourced settings. Interpretation should consider the cross-sectional design and self-reported outcomes; longitudinal studies with external validation and clinically adjudicated endpoints are warranted.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。